A Study of TAK-853 in Adult Participants With Folate Receptor Alpha-Positive Advanced Ovarian Cancer And Other Solid Tumors
Clinical trial NCT06390995 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06390995
- Sponsor
- Takeda
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-20
- Primary completion
- 2025-04-16
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.